Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Plos One|July 7, 2015
Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide RegistersElske Sieswerda, Anna Font-Gonzalez, Marcel G W Dijkgraaf, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 26, 2013
Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal studyRenée L Mulder, Sebastiaan L Knijnenburg, Ronald B Geskus, et al.
Pediatric Blood & Cancer|January 3, 2013
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupLeontien C M Kremer, Renée L Mulder, Kevin C Oeffinger, et al.
Archives of Internal Medicine|July 28, 2010
Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up studyHelena J van der Pal, Elvira C van Dalen, Michael Hauptmann, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 24, 2015
Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern AnalysisReineke A Schoot, Peerooz Saeed, Nicole J Freling, et al.
The Cochrane Database of Systematic Reviews|July 8, 2011
Hepatic late adverse effects after antineoplastic treatment for childhood cancerRenée L Mulder, Elvira C van Dalen, Malon Van den Hof, et al.
European Journal of Cancer (Oxford, England : 1990)|January 6, 2009
Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaeniaFlorine N J Frakking, Nannette Brouwer, Marianne D van de Wetering, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2008
PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastomaJanine Stutterheim, Annemieke Gerritsen, Lily Zappeij-Kannegieter, et al.
Oncotarget|April 9, 2016
High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibitionLaurel T Bate-Eya, Ilona J M den Hartog, Ida van der Ploeg, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2013
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumoursLaurel T Bate-Eya, Marli E Ebus, Jan Koster, et al.
Pageof 13